Clinical Trials Browser

Withdrawn × Rosuvastatin Calcium × Breast × Clear all

NCT02483871 2017-06-05

Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy

Phase 1 Withdrawn

Breast Neoplasms